Elevated ACSL4 levels, accompanied by increased mitochondrial phospholipid biosynthesis and fatty acid oxidation, promote anti-apoptosis in chemoresistant breast cancer, and ACSL4 silencing suppresses tumor growth and induces apoptosis [68]. Here, ACSL4 is linked to breast carcinoma.